Abstract:Aim: To investigate the abundance and potential diagnostic significance of neuroligin-1 and glutamate (Glu) in Hirschsprung's disease (HSCR). Methods: Ninety children with HSCR and 50 children without HSCR matched for similar nutritional status, age and basal metabolic index were studied. The expression and localization of neuroligin-1 and Glu were assessed using double-labeling immunofluorescence staining of longitudinal muscles with adherent myenteric plexus from the surgically excised colon of children with HSCR. Western blot analysis, quantitative real-time PCR (qRT-PCR) and immunohistochemistry were performed to evaluate the abundance of neuroligin-1 and Glu in different HSCR-affected segments (ganglionic, transitional, and aganglionic segments). Enzyme-linked immunosorbent assay (ELISA) was used to detect and compare serum Glu levels in the long-segment HSCR, short-segment HSCR and non-HSCR samples. Results: Neuroligin-1 and Glu were co-expressed highest to lowest in the ganglionic, transitional and aganglionic segments based on Western blot (neuroligin-1: 0.177 ± 0.008 vs 0.101 ± 0.006, 0.177 ± 0.008 vs 0.035 ± 0.005, and 0.101 ± 0.006 vs 0.035 ± 0.005, P < 0.005; Glu: 0.198 ± 0.006 vs 0.115 ± 0.008, 0.198 ± 0.006 vs 0.040 ± 0.003, and 0.115 ± 0.008 vs 0.040 ± 0.003, P < 0.005) and qRT-PCR (neuroligin-1: 9.58 × 10(-5) ± 9.94 × 10(-6) vs 2.49 × 10(-5) ± 1.38 × 10(-6), 9.58 × 10(-5) ± 9.94 × 10(-6) vs 7.17 × 10(-6 ±) 1.12 × 10(-6), and 2.49 × 10(-5) ± 1.38 × 10(-6) vs 7.17 × 10(-6) ± 1.12 × 10(-6), P < 0.005). Serum Glu level was the highest to lowest in the non-HSCR, short-type HSCR and long-type HSCR samples based on ELISA (in nmol/μL, 0.93 ± 0.31 vs 0.57 ± 0.25, 0.93 ± 0.31 vs 0.23 ± 0.16, and 0.57 ± 0.25 vs 0.23 ± 0.16, P < 0.005). Conclusion: Neuroligin-1 and Glu may represent new markers of ganglion cells, whose expression may correlate with the pathogenesis, diagnosis, differential diagnosis or classification of HSCR.

Expression and Significance of Neuroligins in Myenteric Cells of Cajal in Hirschsprung's Disease.

Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients

Expression of neurexin and neuroligin in the enteric nervous system and their down-regulated expression levels in Hirschsprung disease

Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease

Characterization of Interstitial Cajal Progenitors Cells and Their Changes in Hirschsprung's Disease.

Expression of Dishevelled Gene in Hirschsprung's Disease.

The Down-Regulation of Neuroligin-2 and the Correlative Clinical Significance of Serum GABA Over-Expression in Hirschsprung’s Disease

Differential Expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung Disease.

Comparative Proteomics of Hirschsprung's Disease

Interstitial cells of Cajal in human colon and in Hirschsprung's disease

Comparative Study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's Disease

Aberrant Development of Enteric Glial Cells in the Colon of Hirschsprung's Disease

Down-regulation of fibronectin and the correlated expression of neuroligin in hirschsprung disease

MLC 20 , MYPT 1 , PP 1 c and CPI-17 expression and phosphorylation in intestinal smooth muscle specimens from patients with Hirschsprung disease

Downregulation of ICCs and PDGFRα+ cells on colonic dysmotility in hirschsprung disease

Abnormal development of circular muscles in aganglionic segments of HSCR patients

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Polymorphisms and Expression of the Wnt8a Gene in Hirschsprung'S Disease

Expression Patterns of Dishevelled-2 in Different Colon Tissue Segments in Hirschsprung's Disease.

Role of Inflammation and the NF-κB Signaling Pathway in Hirschsprung's Disease

Expressions of Neurexin and Neuroligin in the Human and Rodent Enteric Nervous System